制吐剤と吐き気止めの世界市場レポート 2025年

制吐剤と吐き気止めの市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR3.5％で97億米ドルに成長します。予測期間の成長は、研究開発イニシアティブ、経済要因、市場競争と業界動向、疾病パターンの変化、ヘルスケア政策と政策に起因すると考えられます。予測期間における主な動向としては、患者の体験重視の高まり、ヘルスケア政策の変化、非侵襲的治療に対する消費者の嗜好、化学療法や妊娠に関連した吐き気の有病率の上昇、標的療法の出現などが挙げられます。

制吐剤と吐き気止め市場は、がん罹患率の上昇に後押しされています。化学療法はがんの治療法として最も一般的に推奨されるもの1つであり、化学療法誘発性悪心・嘔吐（CINV）はその副作用の1つです。制吐剤は、患者の約60％～70％においてCINVの予防に役立ちます。例えば、2024年4月、米国に本部を置く非営利団体である米国がん協会は、2022年に国内で確認されたがん関連の死亡者数を約609,000人と予測し、新たに190万人のがん患者が発生すると予測しました。がんによる死亡者数は推定62万人と予想されており、2024年の死亡率はわずかに上昇することを示しています。がんの罹患率が上昇するにつれて、制吐剤と吐き気止めの需要は増加し、市場収益を押し上げると思われます。

結核の有病率の増加が制吐剤と吐き気止め市場の拡大を牽引すると予測されます。結核は主に肺に感染する細菌性疾患です。制吐剤と吐き気止めは、抗結核薬による吐き気や嘔吐の管理に使用されます。例えば、2023年11月、スイスに本部を置く政府間機関である世界保健機関（WHO）が発表した「Global Tuberculosis Report 2023」によると、2022年に世界で結核に罹患した人は約1,060万人（95％不確実性区間は990万人から1,140万人）で、2021年の1,030万人から増加しています。このように、結核の有病率の増加は、制吐剤と吐き気止め市場の成長を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界制吐剤と吐き気止めPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の制吐剤と吐き気止め市場：成長率分析
• 世界の制吐剤と吐き気止め市場の実績：規模と成長, 2019-2024
• 世界の制吐剤と吐き気止め市場の予測：規模と成長, 2024-2029, 2034F
• 世界制吐剤と吐き気止め総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の制吐剤と吐き気止め市場薬物による、実績と予測, 2019-2024, 2024-2029F, 2034F
• ドーパミン拮抗薬
• NK1受容体拮抗薬
• 抗ヒスタミン薬（H1ヒスタミン受容体拮抗薬）
• カンナビノイド
• ベンゾジアゼピン
• 抗コリン薬
• ステロイド
• 5-HT3受容体拮抗薬
• その他の薬物の種類
• 世界の制吐剤と吐き気止め市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 乗り物酔い
• 胃腸炎
• 全身麻酔
• オピオイド鎮痛剤
• めまい
• 妊娠
• 食中毒
• 精神的ストレス
• その他のアプリケーションの種類
• 世界の制吐剤と吐き気止め市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 医療センター
• クリニック
• 調査機関
• 世界の制吐剤と吐き気止め市場、ドーパミン拮抗薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• メトクロプラミド
• プロクロルペラジン
• ドンペリドン
• 世界の制吐剤と吐き気止め市場NK1受容体拮抗薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アプレピタント
• フォサプレピタント
• ロラピタント
• 世界の制吐剤と吐き気止め市場抗ヒスタミン薬（H1ヒスタミン受容体拮抗薬）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ジメンヒドリナート
• メクリジン
• ジフェンヒドラミン
• 世界の制吐剤と吐き気止め市場、カンナビノイドのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ドロナビノール
• ナビロン
• 世界の制吐剤と吐き気止め市場ベンゾジアゼピンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ロラゼパム
• ジアゼパム
• 世界の制吐剤と吐き気止め市場抗コリン薬の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• スコポラミン
• グリコピロレート
• 世界の制吐剤と吐き気止め市場ステロイドのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• デキサメタゾン
• メチルプレドニゾロン
• 世界の制吐剤と吐き気止め市場5-HT3受容体拮抗薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンダンセトロン
• グラニセトロン
• パロノセトロン
• 世界の制吐剤と吐き気止め市場、その他の薬剤タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハーブ療法
• 指圧器具

第7章 地域別・国別分析

• 世界の制吐剤と吐き気止め市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の制吐剤と吐き気止め市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 制吐剤と吐き気止め市場：競合情勢
• 制吐剤と吐き気止め市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi SA
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Cipla Ltd.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• Kyowa Hakko Kirin Pharma Co. Ltd.
• Daiichi Sankyo Company
• Braun GmbH
• Eisai Co. Ltd.
• Sun Pharmaceuticals Industries Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 制吐剤と吐き気止め市場2029：新たな機会を提供する国
• 制吐剤と吐き気止め市場2029：新たな機会を提供するセグメント
• 制吐剤と吐き気止め市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Antiemetics and antinauseants are medications employed in the prevention or management of vomiting resulting from emetogenic chemotherapy and for addressing postoperative nausea and vomiting. These drugs are effective in preventing, controlling, or treating nausea and vomiting triggered by various factors, including other medications, motion sickness, infections, stomach flu, or chemotherapy. Their mechanism of action involves blocking signal messages to the brain's nausea and vomiting control center, thus alleviating the symptoms.

The primary categories of drugs within the realm of antiemetics and antinauseants encompass dopamine antagonists, NK1 receptor antagonists, antihistamines (H1 histamine receptor antagonists), cannabinoids, benzodiazepines, anticholinergics, steroids, 5-HT3 receptor antagonists, and others. Dopamine antagonists, also known as anti-dopaminergics or dopamine receptor antagonists, function by blocking dopamine receptors and find applications in chemotherapy, motion sickness, gastroenteritis, general anesthetics, opioid analgesics, dizziness, pregnancy, food poisoning, emotional stress, and various other contexts. These medications are utilized in diverse healthcare settings, including hospitals, medical centers, clinics, and research institutes.

The antiemetics and antinauseants market research report are one of a series of new reports from The Business Research Company that provides antiemetics and antinauseants market statistics, including antiemetics and antinauseants industry global market size, regional shares, competitors with antiemetics and antinauseants market share, detailed antiemetics and antinauseants market segments, market trends and opportunities, and any further data you may need to thrive in the antiemetics and antinauseants industry. This antiemetics and antinauseants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antiemetics and antinauseants market size has grown steadily in recent years. It will grow from $8.11 billion in 2024 to $8.45 billion in 2025 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to historical branding and market competition, historical treatment preferences, economic conditions, historical global health events, medical advancements and research.

The antiemetics and antinauseants market size is expected to see steady growth in the next few years. It will grow to $9.7 billion in 2029 at a compound annual growth rate (CAGR) of 3.5%. The growth in the forecast period can be attributed to research and development initiatives, economic factors, market competition and industry trends, changing disease patterns, healthcare policies and regulations. Major trends in the forecast period include increased focus on patient experience, changing healthcare policies, consumer preference for non-invasive treatments, rising prevalence of chemotherapy and pregnancy-related nausea, emergence of targeted therapies.

The antiemetics and antinauseants market is propelled by the rising prevalence of cancer. Chemotherapy is one of the most commonly recommended treatments for cancer, and chemotherapy-induced nausea and vomiting (CINV) are among its side effects. Antiemetics can help prevent CINV in approximately 60%-70% of patients. For instance, in April 2024, the American Cancer Society, a non-profit organization based in the United States, projected around 609,000 cancer-related deaths and anticipated 1.9 million new cancer cases identified in the country in 2022. An estimated 620,000 cancer deaths are expected, indicating a slight increase in mortality rates for 2024. As the incidence of cancer rises, the demand for antiemetics and antinauseants will increase, thereby boosting market revenue.

The growing prevalence of tuberculosis is anticipated to drive the expansion of the antiemetics and antinauseants market. Tuberculosis (TB) is an infectious bacterial disease that primarily affects the lungs. Antiemetics and antinauseants are used to manage nausea and vomiting caused by anti-tuberculosis medications. For instance, in November 2023, the Global Tuberculosis Report 2023 published by the World Health Organization, a Switzerland-based intergovernmental organization, stated that approximately 10.6 million individuals (with a 95% uncertainty interval of 9.9 to 11.4 million) contracted tuberculosis globally in 2022, up from 10.3 million cases in 2021. Thus, the increased prevalence of tuberculosis is expected to drive growth in the antiemetics and antinauseants market.

Major companies in the antiemetic and antinauseant markets are focusing on new product innovations, such as ready-to-use injectables, to simplify treatment processes and improve patient compliance. These ready-to-use formulations are designed for immediate effectiveness, minimizing the time and complexity associated with traditional injectable medications. For example, in July 2024, Amneal Pharmaceuticals, a US-based specialty pharmaceutical company, introduced FOCINVEZ, the first ready-to-use injectable formulation of fosaprepitant aimed at preventing acute and delayed nausea and vomiting related to highly emetogenic cancer chemotherapy. This product comes in a 150 mg/50 mL vial, is free of Polysorbate 80, and requires no reconstitution or dilution, enabling direct administration. FOCINVEZ is approved for use in adults and pediatric patients aged six months and older and has received a unique J-Code (J1434) for reimbursement.

Government agencies such as the US Food and Drug Administration (FDA) regulate the antiemetics and antinauseants market. In the USA, specific regulations outlined in title 21 of the FDA's Department of Health and Human Services govern the conditions that antiemetic and antinauseant drugs must fulfill to remain in the market, covering definitions, regulations, and labeling requirements.

Major companies in the antiemetic and antinauseant markets are focusing on new product innovations, such as metal-free nasal spray pumps, to address customer needs in the market. A metal-free nasal spray pump is a dispensing device designed without metal components, ensuring compatibility with sensitive formulations like saline solutions or pharmaceutical sprays. For example, in January 2023, Aptar Pharma, a US-based company that specializes in designing and manufacturing drug delivery systems, introduced the APF Futurity nasal spray pump to meet the growing demand for sustainable, recyclable pharmaceutical packaging. With a metal-free design for easier recycling, the APF Futurity has achieved Class A recyclability certification in European streams. Its user-friendly design allows for disposal as a single unit, while advanced dosing technology ensures accurate delivery. This innovative pump integrates Aptar's Advanced Preservative-Free (APF) technology with improved recyclability, providing a sustainable yet high-performance packaging solution.

Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy's Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

North America was the largest region in the antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antiemetics and antinauseants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The antiemetics and antinauseants market consists of sales of dopamine, serotonin, neurokinin, histamine, and acetylcholine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antiemetics And Antinauseants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antiemetics and antinauseants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antiemetics and antinauseants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antiemetics and antinauseants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug: Dopamine antagonists; NK1 receptor antagonist; Antihistamines (H1 histamine receptor antagonists); Cannabinoids; Benzodiazepines; Anticholinergics; Steroids; 5-HT3 receptor antagonists; Other Drug Types
• 2) By Application: Chemotherapy; Motion sickness; Gastroenteritis; General anesthetics; Opioid analgesics; Dizziness; Pregnancy; Food poisoning; Emotional stress; Other Application Types
• 3) By End Users: Hospital; Medical Center; Clinic; Research Institutes
• Subsegments:
• 1) By Dopamine Antagonists: Metoclopramide; Prochlorperazine; Domperidone
• 2) By NK1 Receptor Antagonists: Aprepitant; Fosaprepitant; Rolapitant
• 3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate; Meclizine; Diphenhydramine
• 4) By Cannabinoids: Dronabinol; Nabilone
• 5) By Benzodiazepines: Lorazepam; Diazepam
• 6) By Anticholinergics: Scopolamine; Glycopyrrolate
• 7) By Steroids: Dexamethasone; Methylprednisolone
• 8) By 5-HT3 Receptor Antagonists: Ondansetron; Granisetron; Palonosetron
• 9) By Other Drug Types: Herbal Remedies; Acupressure Devices
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antiemetics And Antinauseants Market Characteristics

3. Antiemetics And Antinauseants Market Trends And Strategies

4. Antiemetics And Antinauseants Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Antiemetics And Antinauseants Growth Analysis And Strategic Analysis Framework

• 5.1. Global Antiemetics And Antinauseants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Antiemetics And Antinauseants Market Growth Rate Analysis
• 5.4. Global Antiemetics And Antinauseants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Antiemetics And Antinauseants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Antiemetics And Antinauseants Total Addressable Market (TAM)

6. Antiemetics And Antinauseants Market Segmentation

• 6.1. Global Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dopamine antagonists
• NK1 receptor antagonist
• Antihistamines (H1 histamine receptor antagonists)
• Cannabinoids
• Benzodiazepines
• Anticholinergics
• Steroids
• 5-HT3 receptor antagonists
• Other Drug Types
• 6.2. Global Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Motion sickness
• Gastroenteritis
• General anesthetics
• Opioid analgesics
• Dizziness
• Pregnancy
• Food poisoning
• Emotional stress
• Other Application Types
• 6.3. Global Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Medical Center
• Clinic
• Research Institutes
• 6.4. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Dopamine Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metoclopramide
• Prochlorperazine
• Domperidone
• 6.5. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of NK1 Receptor Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aprepitant
• Fosaprepitant
• Rolapitant
• 6.6. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Antihistamines (H1 Histamine Receptor Antagonists), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dimenhydrinate
• Meclizine
• Diphenhydramine
• 6.7. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dronabinol
• Nabilone
• 6.8. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Benzodiazepines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lorazepam
• Diazepam
• 6.9. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Anticholinergics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Scopolamine
• Glycopyrrolate
• 6.10. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dexamethasone
• Methylprednisolone
• 6.11. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of 5-HT3 Receptor Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ondansetron
• Granisetron
• Palonosetron
• 6.12. Global Antiemetics And Antinauseants Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Herbal Remedies
• Acupressure Devices

7. Antiemetics And Antinauseants Market Regional And Country Analysis

• 7.1. Global Antiemetics And Antinauseants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Antiemetics And Antinauseants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antiemetics And Antinauseants Market

• 8.1. Asia-Pacific Antiemetics And Antinauseants Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antiemetics And Antinauseants Market

• 9.1. China Antiemetics And Antinauseants Market Overview
• 9.2. China Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antiemetics And Antinauseants Market

• 10.1. India Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antiemetics And Antinauseants Market

• 11.1. Japan Antiemetics And Antinauseants Market Overview
• 11.2. Japan Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antiemetics And Antinauseants Market

• 12.1. Australia Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antiemetics And Antinauseants Market

• 13.1. Indonesia Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antiemetics And Antinauseants Market

• 14.1. South Korea Antiemetics And Antinauseants Market Overview
• 14.2. South Korea Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antiemetics And Antinauseants Market

• 15.1. Western Europe Antiemetics And Antinauseants Market Overview
• 15.2. Western Europe Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antiemetics And Antinauseants Market

• 16.1. UK Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antiemetics And Antinauseants Market

• 17.1. Germany Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antiemetics And Antinauseants Market

• 18.1. France Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antiemetics And Antinauseants Market

• 19.1. Italy Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antiemetics And Antinauseants Market

• 20.1. Spain Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antiemetics And Antinauseants Market

• 21.1. Eastern Europe Antiemetics And Antinauseants Market Overview
• 21.2. Eastern Europe Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antiemetics And Antinauseants Market

• 22.1. Russia Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antiemetics And Antinauseants Market

• 23.1. North America Antiemetics And Antinauseants Market Overview
• 23.2. North America Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antiemetics And Antinauseants Market

• 24.1. USA Antiemetics And Antinauseants Market Overview
• 24.2. USA Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antiemetics And Antinauseants Market

• 25.1. Canada Antiemetics And Antinauseants Market Overview
• 25.2. Canada Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antiemetics And Antinauseants Market

• 26.1. South America Antiemetics And Antinauseants Market Overview
• 26.2. South America Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antiemetics And Antinauseants Market

• 27.1. Brazil Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antiemetics And Antinauseants Market

• 28.1. Middle East Antiemetics And Antinauseants Market Overview
• 28.2. Middle East Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antiemetics And Antinauseants Market

• 29.1. Africa Antiemetics And Antinauseants Market Overview
• 29.2. Africa Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antiemetics And Antinauseants Market Competitive Landscape And Company Profiles

• 30.1. Antiemetics And Antinauseants Market Competitive Landscape
• 30.2. Antiemetics And Antinauseants Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Antiemetics And Antinauseants Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. AstraZeneca plc
• 31.3. Abbott Laboratories
• 31.4. GlaxoSmithKline plc
• 31.5. Cipla Ltd.
• 31.6. Eli Lilly and Company
• 31.7. F. Hoffmann-La Roche Ltd.
• 31.8. Baxter International Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Astellas Pharma Inc.
• 31.11. Kyowa Hakko Kirin Pharma Co. Ltd.
• 31.12. Daiichi Sankyo Company
• 31.13. Braun GmbH
• 31.14. Eisai Co. Ltd.
• 31.15. Sun Pharmaceuticals Industries Ltd.

32. Global Antiemetics And Antinauseants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antiemetics And Antinauseants Market

34. Recent Developments In The Antiemetics And Antinauseants Market

35. Antiemetics And Antinauseants Market High Potential Countries, Segments and Strategies

• 35.1 Antiemetics And Antinauseants Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Antiemetics And Antinauseants Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Antiemetics And Antinauseants Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer